Project ENVOL reaches a new media milestone with a featured article in the latest issue of Bref Eco, the leading economic news outlet in the Auvergne-Rhône-Alpes region.
A Revolution in Biocompatibility Testing
The article highlights the ambition of the consortium -of which Maison MGA is a key member: developing a 3D skin model on a microfluidic chip that is both innervated and immunocompetent. Supported by the France 2030 investment plan, this project aims to provide a technological and ethical alternative to animal testing for the healthcare and beauty industries.
MGA MedTech: The Industrial Backbone
As noted in the article, the success of ENVOL depends on its ability to move from the laboratory to industrial-scale production. This is where MGA MedTech’s expertise comes into play. Our teams are focusing on:
- Designing high-precision instruments and consumables.
- Standardizing processes to ensure reproducible results.
- Meeting regulatory requirements for a market launch within the next four years.
We are proud to see our medical engineering expertise recognized as a vital driver of this “Made in Aura” innovation.
Read the full article on page 9:
Bref_2659

